Cargando…

Web-Based Patient-Reported Outcomes for ENT Patients—Evaluation of the Status Quo, Patients’ View, and Future Perspectives

Background: Patient-reported outcomes (PRO) assess disease burden and indicate unmet needs. Home-based electronic PRO measures (ePROMs) can support tumor aftercare (TAC). Creating an ePROM is the next step after implementing the software “OncoFunction” to assess PROs during TAC of head- and neck-can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wald, Theresa, Zebralla, Veit, Boege, Maren, Kunz, Viktor, Neumuth, Thomas, Dietz, Andreas, Wichmann, Gunnar, Wiegand, Susanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9517261/ https://www.ncbi.nlm.nih.gov/pubmed/36142048 http://dx.doi.org/10.3390/ijerph191811773

Ejemplares similares

Frailty Assessed with FRAIL Scale and G8 Questionnaire Predicts Severe Postoperative Complications in Patients Receiving Major Head and Neck Surgery
por: Kunz, Viktor, et al.
Publicado: (2022)

Choosing the Right Treatment Option for the Right R/M HNSCC Patient: Should We Adhere to PFE for First-Line Therapy?
por: Lübbers, Katharina, et al.
Publicado: (2021)

Obtaining Patient-Reported Outcomes Electronically With “OncoFunction” in Head and Neck Cancer Patients During Aftercare
por: Zebralla, Veit, et al.
Publicado: (2020)

Course of Self-Reported Dysphagia, Voice Impairment and Pain in Head and Neck Cancer Survivors
por: Zebralla, Veit, et al.
Publicado: (2021)

Immune checkpoint blockade induced shifts in cytokine expression patterns in peripheral blood of head and neck cancer patients are linked to outcome
por: Röhl, Louisa, et al.
Publicado: (2023)

Dysphagia, voice problems, and pain in head and neck cancer patients
por: Zebralla, Veit, et al.
Publicado: (2021)

Standardized Diagnostics Including PET-CT Imaging, Bilateral Tonsillectomy and Neck Dissection Followed by Risk-Adapted Post-Operative Treatment Favoring Radio-Chemotherapy Improve Survival of Neck Squamous Cell Carcinoma of Unknown Primary Patients
por: Wichmann, Gunnar, et al.
Publicado: (2021)

High-Risk Human Papillomavirus (HR-HPV) DNA Detection in Mouthwashes for Diagnosis of HPV-Driven Oropharynx Cancer and Its Curative Therapy—A Feasibility Study
por: Loermann, Gera, et al.
Publicado: (2022)

Standardized Diagnostic Workup and Patient-Centered Decision Making for Surgery and Neck Dissection Followed by Risk-Factor Adapted Adjuvant Therapy Improve Loco-Regional Control in Local Advanced Oral Squamous Cell Carcinoma
por: Wichmann, Gunnar, et al.
Publicado: (2021)

Depression, anxiety, fatigue, and quality of life in a large sample of patients suffering from head and neck cancer in comparison with the general population
por: Hammermüller, C., et al.
Publicado: (2021)

Cytokine Profiles of Head and Neck Squamous Cell Carcinoma Undergoing Dual Immunotherapy With Cetuximab and Pembrolizumab Identify Interferon Gamma-Induced Protein 10 as Novel Biomarker
por: Berszin, Michael, et al.
Publicado: (2022)

Monitoring and Evaluation of Late Functional Outcome in Post-treatment Follow-Up in Clinical Routine Setting
por: Zebralla, Veit, et al.
Publicado: (2019)

Keyword-augmented and semi-automatic generation of FESS reports: a proof-of-concept study
por: Kunz, V., et al.
Publicado: (2022)

Pre-Therapeutic VEGF Level in Plasma Is a Prognostic Bio-Marker in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Siemert, Julia, et al.
Publicado: (2021)

Reduced Cytokine Release in Ex Vivo Response to Cilengitide and Cetuximab Is a Marker for Improved Survival of Head and Neck Cancer Patients
por: Cedra, Susan, et al.
Publicado: (2017)

Perspectives of Induction With Chemo and/or Immune Check Point Inhibition in Head and Neck Organ Preservation Treatment
por: Wiegand, Susanne, et al.
Publicado: (2019)

Malignant Vascular Tumors of the Head and Neck—Which Type of Therapy Works Best?
por: Wiegand, Susanne, et al.
Publicado: (2021)

Laryngeal Preservation Approaches: Considerations for New Selection Criteria Based on the DeLOS-II Trial
por: Dietz, Andreas, et al.
Publicado: (2019)

Development of a Human Leukocyte Antigen Score to Predict Progression-Free Survival in Head and Neck Squamous Cell Carcinoma Patients
por: Wichmann, Gunnar, et al.
Publicado: (2018)

Is High-Risk Sexual Behavior a Risk Factor for Oropharyngeal Cancer?
por: Wichmann, Gunnar, et al.
Publicado: (2023)

Discrimination of Head and Neck Squamous Cell Carcinoma Patients and Healthy Adults by 10-Color Flow Cytometry: Development of a Score Based on Leukocyte Subsets
por: Wichmann, Gunnar, et al.
Publicado: (2019)

Screening for distress, related problems and perceived need for psycho-oncological support in head and neck squamous cell carcinoma (HNSCC) patients: a retrospective cohort study
por: Kunz, V., et al.
Publicado: (2021)

Invasive Growth of Ailanthus altissima Trees is Associated with a High Rate of Sensitization in Atopic Patients
por: Prenzel, Freerk, et al.
Publicado: (2022)

Bayesian Networks to Support Decision-Making for Immune-Checkpoint Blockade in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Huehn, Marius, et al.
Publicado: (2021)

Lipedema Research—Quo Vadis?
por: Ernst, Anna M., et al.
Publicado: (2022)

ENT manifestation in COVID-19 patients
por: El-Anwar, Mohammad Waheed, et al.
Publicado: (2020)

Self-medication profile of ENT patients
por: Servidoni, Alexandre Barbosa, et al.
Publicado: (2015)

Dengue — Quo tu et quo vadis?
por: Chen, Rubing, et al.
Publicado: (2011)

Rheumatologie – quo vadis? Gesundheitssystem – quo vadis?
por: Puchner, Rudolf
Publicado: (2023)

ENT
por: Zodda, David
Publicado: (2020)

Quo vadis?
por: Sienkiewicz, Henryk, 1846-1916
Publicado: (1943)

“Quo Vadis?”
por: Bereen, J. F.
Publicado: (1964)

Quo vadis? /
por: Sienkiewicz, Henryk, 1846-1916

Quo Vadis?
Publicado: (1902)

Quo Modo?
Publicado: (1856)

Quo Vadis?
por: Happel, T. J.
Publicado: (1899)

Association between malformation type, location and functional deficits in lymphatic malformations of the head and neck in children
por: Wiegand, Susanne, et al.
Publicado: (2023)

Gastroenterology Meets Machine Learning: Status Quo and Quo Vadis
por: Adadi, Amina, et al.
Publicado: (2019)

PF‐07321332 (Nirmatrelvir) does not interact with human ENT1 or ENT2: Implications for COVID‐19 patients
por: Hau, Raymond K., et al.
Publicado: (2022)

On Programmed Cell Death in Plasmodium falciparum: Status Quo
por: Engelbrecht, Dewaldt, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_k35pp7idrc4nmtks7427d5tr8q